依那西普-话题@MedSci

#依那西普#

27篇内容 | 1451人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1340437, encodeId=80f0134043ef9, content=<a href='/topic/show?id=e4ed2693895' target=_blank style='color:#2F92EE;'>#依那西普#</a>, objectTitle=Lancet：治疗中度至重度银屑病，ixekizumab优于依那西普, objectType=article, longId=52002, objectId=b83e5200272, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b83e5200272, replyNumber=0, likeNumber=25, createdTime=2015-06-13, rootId=0, userName=ms1490123962508630, userId=ca772500164, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b83e5200272, moduleTitle=Lancet：治疗中度至重度银屑病，ixekizumab优于依那西普, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b83e5200272)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1340436, encodeId=7b7713404366b, content=<a href='/topic/show?id=e4ed2693895' target=_blank style='color:#2F92EE;'>#依那西普#</a>, objectTitle=Lancet：托法替尼和依那西普治疗中重度斑块型银屑病, objectType=article, longId=51736, objectId=198051e3631, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=198051e3631, replyNumber=0, likeNumber=33, createdTime=2015-06-07, rootId=0, userName=ms1490123962508630, userId=ca772500164, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=198051e3631, moduleTitle=Lancet：托法替尼和依那西普治疗中重度斑块型银屑病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=198051e3631)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1340435, encodeId=9a90134043536, content=<a href='/topic/show?id=e4ed2693895' target=_blank style='color:#2F92EE;'>#依那西普#</a>, objectTitle=AAIC 2014：关节炎药物依那西普显示出减缓阿尔茨海默氏症功效, objectType=article, longId=38051, objectId=7e6338051f2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7e6338051f2, replyNumber=0, likeNumber=26, createdTime=2014-07-23, rootId=0, userName=ms1490123962508630, userId=ca772500164, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7e6338051f2, moduleTitle=AAIC 2014：关节炎药物依那西普显示出减缓阿尔茨海默氏症功效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7e6338051f2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1340434, encodeId=4747134043450, content=<a href='/topic/show?id=e4ed2693895' target=_blank style='color:#2F92EE;'>#依那西普#</a>, objectTitle=依那西普与修美乐仍是美国RA一线生物治疗药物的“中流砥柱”, objectType=article, longId=25176, objectId=837e251e6c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=837e251e6c0, replyNumber=0, likeNumber=0, createdTime=2013-10-02, rootId=0, userName=ms1490123962508630, userId=ca772500164, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=837e251e6c0, moduleTitle=依那西普与修美乐仍是美国RA一线生物治疗药物的“中流砥柱”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=837e251e6c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1340433, encodeId=eaf1134043320, content=<a href='/topic/show?id=e4ed2693895' target=_blank style='color:#2F92EE;'>#依那西普#</a>, objectTitle=Rheumatology：治疗儿童特发性关节炎时风湿科医师选择依那西普更多, objectType=article, longId=24593, objectId=efd924593a8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=efd924593a8, replyNumber=0, likeNumber=31, createdTime=2013-09-19, rootId=0, userName=ms1490123962508630, userId=ca772500164, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=efd924593a8, moduleTitle=Rheumatology：治疗儿童特发性关节炎时风湿科医师选择依那西普更多, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=efd924593a8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1340432, encodeId=ed27134043224, content=<a href='/topic/show?id=e4ed2693895' target=_blank style='color:#2F92EE;'>#依那西普#</a>, objectTitle=诺华旗下Secukinumab在银屑病临床研究中胜过依那西普, objectType=article, longId=21183, objectId=6dd7211832f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6dd7211832f, replyNumber=0, likeNumber=24, createdTime=2013-07-13, rootId=0, userName=ms1490123962508630, userId=ca772500164, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6dd7211832f, moduleTitle=诺华旗下Secukinumab在银屑病临床研究中胜过依那西普, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6dd7211832f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1340431, encodeId=2b141340431a0, content=<a href='/topic/show?id=e4ed2693895' target=_blank style='color:#2F92EE;'>#依那西普#</a>, objectTitle=Lancet：依那西普维持治疗可控制类风湿关节炎疾病活动, objectType=article, longId=14914, objectId=c81a14914be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c81a14914be, replyNumber=0, likeNumber=40, createdTime=2013-01-31, rootId=0, userName=ms1490123962508630, userId=ca772500164, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c81a14914be, moduleTitle=Lancet：依那西普维持治疗可控制类风湿关节炎疾病活动, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c81a14914be)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

依那西普

2020-05-29

ms1490123962508630 (审核中...)

前往app查看评论内容

#依那西普#

Lancet：治疗中度至重度银屑病，ixekizumab优于依那西普

2015-06-13

ms1490123962508630 (审核中...)

前往app查看评论内容

#依那西普#

Lancet：托法替尼和依那西普治疗中重度斑块型银屑病

2015-06-07

ms1490123962508630 (审核中...)

前往app查看评论内容

#依那西普#

AAIC 2014：关节炎药物依那西普显示出减缓阿尔茨海默氏症功效

2014-07-23

ms1490123962508630 (审核中...)

前往app查看评论内容

#依那西普#

依那西普与修美乐仍是美国RA一线生物治疗药物的“中流砥柱”

2013-10-02

ms1490123962508630 (审核中...)

前往app查看评论内容

#依那西普#

Rheumatology：治疗儿童特发性关节炎时风湿科医师选择依那西普更多

2013-09-19

ms1490123962508630 (审核中...)

前往app查看评论内容

#依那西普#

诺华旗下Secukinumab在银屑病临床研究中胜过依那西普

2013-07-13

ms1490123962508630 (审核中...)

前往app查看评论内容

#依那西普#

Lancet：依那西普维持治疗可控制类风湿关节炎疾病活动

2013-01-31

科室
- - 订阅+
  - 更多科室
工具
服务